The interaction between IGF and its receptor triggers the activation of phosphatidylinositol‐3‐kinase (PI3K)/Akt and ERK signaling pathways, ultimately leading to cancer cell survival, proliferation, and migration (Thomas & Radhakrishnan, 2020). The gene discussed is IGF1; the disease is cancer.